We found and identified five heterozygous dysfibrinogenemias with γN308K (AAT→AAG) mutation in three families by coagulation screening tests and direct sequence analysis of PCR-amplified DNA fragments. Three dysfibrinogens were designated as fibrinogens Matsumoto II, Matsumoto XI, and Nagano I. The patients
’ fibrinogens purified from plasma using immunoaffinity-chromatography were subjected to thrombin-catalyzed fibrin polymerization. In the absence of Ca
2+, the patients’ fibrinogens showed impaired thrombin-catalyzed fibrin polymerization in comparison with normal control fibrinogen. On the other hand, in the presence of 1.0 mM Ca
2+, the polymerization of all the patients
’ fibrinogen was improved as compared with those in the absence of Ca
2+. Although Single Nucleotide Polymorphism (SNPs) analysis showed that all patients might be derived from a single proband of mutation, the degree of impairment of polymerization was markedly different among affected patient’s fibrinogens. Moreover, SDS-PAGE analysis indicated that the ratio of the amount of the mutant γ-chain to that of the normal γ-chain was not significantly different among the affected patients
’ fibrinogens. In conclusion, we speculate that the increase in the amount of heterodimers consisting of normal and mutant γ-chains (namely, the decrease in the amount of homodimers consisting of the normal γ-chain) leads to the marked impairment of thrombin-catalyzed fibrin polymerization.
View full abstract